Literature DB >> 24410559

Assessing schizophrenia-relevant cognitive and social deficits in mice: a selection of mouse behavioral tasks and potential therapeutic compounds.

Wen-Sung Lai, Chia-Yuan Chang, Wan-Rong Wong, Ju-Chun Pei, Ya-Shan Chen, Wei-Li Hung1.   

Abstract

Schizophrenia and other psychiatric disorders are generally diagnosed based on a collection of symptoms defined by a combination of an individual's feelings, perceptions, and behaviors. Many of these disorders are characterized by specific cognitive and social deficits. Although it is nearly impossible to recapitulate the full phenotypic spectrum of schizophrenia in mice, mouse models play an indispensable role in understanding the pathogenesis of this disorder and the development of new therapeutics. Genetic mouse models of schizophrenia and mouse behavioral tests provide a feasible approach for elucidating causal relationships between susceptibility gene(s) and schizophrenia-related symptoms. There has been a proliferation of studies characterizing basic behavioral phenotypes in mice. Since there is no way to completely model human psychiatric symptoms in mice, the major role of behavioral tests is to provide insights into underlying affected circuitry and pathophysiology. Given that the recovery of cognitive and social abilities significantly benefits functional outcomes, there has been an increasing interest in characterizing cognitive and social functions in mutant mice; however, these functions are not easy to measure. In this review, a selection of conventional behavioral tasks was briefly described and three specific behavioral tasks aimed at characterizing social communication, attentional function, and choice behavior in mice were highlighted. The choice of specific behavioral tasks during experimental planning should take into consideration a variety of factors, including their validity, reliability, sensitivity, utility, and specificity. Based upon the hypothetical hypofunction of N-methyl-D-aspartate receptor (NMDAR)-mediated signaling pathways in the involvement of cognitive and social impairments in schizophrenia, three NMDAR-related compounds/drugs, D-serine, sarcosine, and D-cycloserine, are discussed as an example.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24410559     DOI: 10.2174/1381612819666140110122750

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.

Authors:  Paul-Christian Bürkner; Donald R Williams; Trenton C Simmons; Josh D Woolley
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

2.  Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits.

Authors:  Ju-Chun Pei; Chih-Min Liu; Wen-Sung Lai
Journal:  Front Behav Neurosci       Date:  2014-04-14       Impact factor: 3.558

3.  Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia.

Authors:  Ching-Hsun Huang; Ju-Chun Pei; Da-Zhong Luo; Ching Chen; Yi-Wen Chen; Wen-Sung Lai
Journal:  Front Behav Neurosci       Date:  2015-01-29       Impact factor: 3.558

4.  Impaired Object Recognition but Normal Social Behavior and Ultrasonic Communication in Cofilin1 Mutant Mice.

Authors:  A Özge Sungur; Lea Stemmler; Markus Wöhr; Marco B Rust
Journal:  Front Behav Neurosci       Date:  2018-02-19       Impact factor: 3.558

Review 5.  Not Just a Bystander: The Emerging Role of Astrocytes and Research Tools in Studying Cognitive Dysfunctions in Schizophrenia.

Authors:  Chia-Yuan Chang; Da-Zhong Luo; Ju-Chun Pei; Ming-Che Kuo; Yi-Chen Hsieh; Wen-Sung Lai
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.